Rosen & Barkin's 5-Minute Emergency Medicine Consult (146 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
5.08Mb size Format: txt, pdf, ePub
ALERT
For patients presenting between 3 and 4.5 hr of onset, there are additional exclusion criteria:
  • Age >80 yr
  • Oral anticoagulant use (regardless of INR)
  • NIH-SS >25 or >1/3 MCA territory involved
  • History of previous stroke
    and
    diabetes
MEDICATION
First Line
  • Alteplase (tPA): 0.9 mg/kg IV; max. 90 mg, with 10% of dose given as bolus and remainder infused over 60 min
  • Aspirin: 81–325 mg PO/PR
  • Labetalol: 10–20 mg IV bolus, repeat q10min max. 300 mg; follow with continuous infusion 0.5–2 mg/min
Second Line
  • Clopidogrel: 75 mg PO daily
  • Diazepam: 5 mg IV q5–10min max. 20 mg
  • Enalapril: 0.675–1.25 mg IV
  • Hydralazine: 10–20 mg IV q30min
  • Mannitol (15–25% solution): 0.5–2 g/kg IV over 5–10 min, then 0.5–1 g/kg q4–q6h
  • Nicardipine: 5 mg/h IV, increase by 2.5 mg/h q5–15min max. 15 mg/h
  • Nitroprusside: 0.25–10 μg/kg/min IV
  • Trimetaphan: 1–4 mg/min IV
Pediatric Considerations
  • Heparin or low-molecular-weight heparin is often used in children with ischemic stroke
  • May call 1-800-NOCLOTS for pediatric stroke consultation and guidance
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Patients with acute cerebral vascular accident should be admitted to hospital
  • Indications for ICU:
    • Severely decreased level of consciousness
    • Hemodynamic instability
    • Life-threatening cardiac dysrhythmias
    • Significantly increased intracranial pressure
    • Administration of alteplase
Discharge Criteria
  • Patients who present with completed strokes that are days to weeks old may be discharged if they are able to function independently or have adequate social support
  • Patients with multiple prior strokes who experience relatively minor new episodes may also be treated on outpatient basis if similar criteria are met and stroke is completed
FOLLOW-UP RECOMMENDATIONS
  • Neurology
  • Primary care
  • Speech therapy/occupational therapy
PEARLS AND PITFALLS
  • Always note pre-hospital observations
  • Onset of symptoms is crucial to determining treatment with tPA
    • Include additional exclusion criteria between 3 and 4.5 hr
  • Avoid aggressive BP correction due to risk of hypoperfusion and extension of stroke
  • Door to needle goal is <60 min
ADDITIONAL READING
  • Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    Ann Emerg Med.
    2013;61:225–243.
  • Freundlich CL, Cervantes-Arslanian AM, Dorfman DH. Pediatric stroke.
    Emerg Med Clin N Am
    . 2012;30:805–828.
  • Fulgham JR, Ingall TJ, Stead LG, et al. Management of acute ischemic stroke.
    Mayo Clin Proc
    . 2004;11:1459–1469.
  • Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professional from American Heart Association/American Stroke Association Stroke Council.
    Stroke
    . 2013;44:870–947.
  • Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcomes of stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
    Lancet
    . 2010;375:1695–1703.
  • Leira EC, Ludwig BR, Gurol ME, et al. The types of neurological deficits might not justify withholding treatment in patients with low National Institutes of Health Stroke Scale scores.
    Stroke
    . 2012;43:782--786.
  • Perry JM, McCabe KK. Recognition and initial management of acute ischemic stroke.
    Emerg Med Clin North Am
    . 2012;30:637–657.
  • www.ninds.nih.gov/doctors
See Also (Topic, Algorithm, Electronic Media Element)
  • Transient Ischemic Attack
  • Intracranial Hemorrhage
CODES
ICD9
  • 434.01 Cerebral thrombosis with cerebral infarction
  • 434.11 Cerebral embolism with cerebral infarction
  • 434.91 Cerebral artery occlusion, unspecified with cerebral infarction
ICD10
  • I63.59 Cereb infrc due to unsp occls or stenosis of cerebral artery
  • I63.8 Other cerebral infarction
  • I63.9 Cerebral infarction, unspecified
CERVICAL ADENITIS
Julie Zeller
BASICS
DESCRIPTION
  • Acute bacterial infection of a cervical lymph node
    • Often arising after a prior bacterial infection of the head or neck area
  • Primarily a pediatric disease:
    • Becoming more common in adults owing to immunocompromised disease states (HIV, cancer, transplant patients)
  • Any cervical node can become infected:
    • >80% of childhood cervical lymphadenitis involves the submandibular or deep cervical nodes
    • Jugulodigastric node located just below the angle of the mandible is common site
    • Cervical nodes act as the final common pathway for lymphatic drainage of all areas of the head and neck
    • Initial lymphadenopathy results after bacterial invasion of regional areas of the head and neck
    • Local lymph nodes swell secondary to hyperplasia of sinusoidal cells and infiltration of lymphocytes
    • If the infection is not contained, the bacteria enter the lymph system and proliferate (lymphadenitis)
    • Pus forms when neutrophils are incited, and an abscess develops when host defenses are unable to clear infection
    • Clinically manifests as warm, tender, swollen, erythematous node
ETIOLOGY
  • ∼70% of cases are a result of group A β-hemolytic Streptococcal infection
    • 20% Staphylococcal infection
    • 10% related to viral infection or other bacteria
  • Infections secondary to community-acquired MRSA (CA-MRSA) have increased in frequency
  • Children have one of the highest rate of CA-MRSA colonization and invasive disease
  • Mycobacteria TB:
    • Scrofula or tuberculous lymphadenitis
    • Rarely seen
    • Usually a chronic lymphadenitis in the posterior cervical nodes
    • Purified protein derivative (PPD) is usually strongly reactive
    • Treatment is nonsurgical
  • Atypical mycobacteria (nontuberculous)
    Mycobacterium avium
    complex:
    • More commonly seen
    • Usually a chronic lymphadenitis in the submandibular or anterior cervical nodes
    • PPD test results are unreliable
    • Treatment is primarily surgical
  • Bartonella henselae
    (catscratch disease):
    • Subacute lymphadenitis
    • Fever and mild systemic symptoms occur in only ∼3% of patients
    • Has indolent course but usually spontaneously resolves after 4–6 wk
  • Anaerobes:
    • Consider when associated with infections of the teeth or gingiva
  • Rare organisms:
    • Gram-negative bacilli
    • Yersinia pestis
    • Group B streptococcus
    • Francisella tularensis
    • Alpha-streptococcus
    • Anthrax
Pediatric Considerations
  • One of the most common causes of a neck mass in a child
  • Overall, group A Streptococcus and
    Staphylococcus aureus
    most common causes
  • In neonates, group B Streptococcus and
    S. aureus
    most common
  • Group B
    Streptococcal cellulitis
    –adenitis syndrome:
    • Infants are usually 3–7 wk of age, male, febrile, with submandibular or facial cellulitis, and an ipsilateral otitis media
    • 94% incidence of concurrent bacteremia
  • S. aureus
    associated with more indolent course and higher frequency of suppuration
  • Viral infections generally result in bilateral lymphadenopathy
Geriatric Considerations
  • Consider malignancy over infection in this population, especially in the absence of fever, leukocytosis, etc.
  • Fixed, nontender, hard node most likely not cervical adenitis
DIAGNOSIS

Other books

Eye of the Storm by Dee Davis
Ghastly Glass by Lavene, Joyce and Jim
Layover by Peaches The Writer
Devil in Disguise by Heather Huffman
A Medal For Murder by Frances Brody
Fashionably Dead in Diapers by Robyn Peterman